highly significantp < 0.001
The primary outcome—median IgE reduction percentage—was 63.8% (IQR: 48.7–76.3) in the parasitic group and 27.0% (IQR: 0.0–58.8) in the non-parasitic group, a difference that was highly significant ( p < 0.001; Figure 1 ).
The primary outcome—median IgE reduction percentage—was 63.8% (IQR: 48.7–76.3) in the parasitic group and 27.0% (IQR: 0.0–58.8) in the non-parasitic group, a difference that was highly significant ( p < 0.001; Figure 1 ).